Literature DB >> 17763975

A significant correlation between nuclear CXCR4 expression and axillary lymph node metastasis in hormonal receptor negative breast cancer.

Sang Uk Woo1, Jeoung Won Bae, Chul Hwan Kim, Jae Bok Lee, Byum Whan Koo.   

Abstract

BACKGROUND AND OBJECTIVES: In breast cancer, the expression pattern of CXCR4 may be correlated with the degree of axillary lymph node involvement. The aim of this study was to evaluate the contributing factors that contribute to the correlation between CXCR4 expression and axillary lymph node metastasis in breast cancer.
METHODS: Between August 1997 and August 2002, sections of paraffin-embedded tissue were obtained from 107 patients who received optimal treatment for breast cancer. The expression of CXCR4 was evaluated by immunohistochemical staining.
RESULTS: A significant correlation was found in the expression of nuclear CXCR4 and lymph node metastasis (P = 0.03). We found a significant correlation between a high nuclear expression of CXCR4 and axillary lymphatic metastasis in estrogen and progesterone receptor negative breast cancer (P = 0.01 and P = 0.01). There was a significant correlation between the high expression of nuclear CXCR4 and axillary lymphatic metastasis in comparisons between positive estrogen and/or progesterone receptor expression and negative expression (P = 0.02).
CONCLUSIONS: Our results showed that high expression of nuclear CXCR4 was significantly correlated with lymph node metastasis in breast cancer. The high expression of nuclear CXCR4 in hormone receptor negative breast cancer was associated with a high possibility of lymph node metastasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17763975     DOI: 10.1245/s10434-007-9595-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  18 in total

1.  CXCR4/CXCL12 expression profile is associated with tumor microenvironment and clinical outcome of liver metastases of colorectal cancer.

Authors:  Nozomu Sakai; Hiroyuki Yoshidome; Takashi Shida; Fumio Kimura; Hiroaki Shimizu; Masayuki Ohtsuka; Dan Takeuchi; Masahiro Sakakibara; Masaru Miyazaki
Journal:  Clin Exp Metastasis       Date:  2011-11-11       Impact factor: 5.150

2.  Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer's structures.

Authors:  David Zagzag; Mine Esencay; Olga Mendez; Herman Yee; Iva Smirnova; Yuanyuan Huang; Luis Chiriboga; Eugene Lukyanov; Mengling Liu; Elizabeth W Newcomb
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

3.  Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status.

Authors:  Lene Rask; Eva Balslev; Rolf Søkilde; Estrid Høgdall; Henrik Flyger; Jens Eriksen; Thomas Litman
Journal:  Cell Oncol (Dordr)       Date:  2014-07-16       Impact factor: 6.730

4.  Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis.

Authors:  Yixin Liu; Ru Ji; Jingyong Li; Qiang Gu; Xiulan Zhao; Tao Sun; Jinjing Wang; Jiangbo Li; Qiuyue Du; Baocun Sun
Journal:  J Exp Clin Cancer Res       Date:  2010-02-24

5.  Gold Nanoclusters Doped with (64)Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and Metastasis.

Authors:  Yongfeng Zhao; Lisa Detering; Deborah Sultan; Matthew L Cooper; Meng You; Sangho Cho; Stephanie L Meier; Hannah Luehmann; Guorong Sun; Michael Rettig; Farrokh Dehdashti; Karen L Wooley; John F DiPersio; Yongjian Liu
Journal:  ACS Nano       Date:  2016-05-18       Impact factor: 15.881

6.  Immunohistochemical detection of the CXCR4 expression in tumor tissue using the fluorescent peptide antagonist Ac-TZ14011-FITC.

Authors:  Nynke S van den Berg; Tessa Buckle; Joeri Kuil; Jelle Wesseling; Fijs W B van Leeuwen
Journal:  Transl Oncol       Date:  2011-08-01       Impact factor: 4.243

Review 7.  Inflammation and cancer: how friendly is the relationship for cancer patients?

Authors:  Bharat B Aggarwal; Prashasnika Gehlot
Journal:  Curr Opin Pharmacol       Date:  2009-08-06       Impact factor: 5.547

8.  Molecular imaging of CXCR4 receptor expression in human cancer xenografts with [64Cu]AMD3100 positron emission tomography.

Authors:  Sridhar Nimmagadda; Mrudula Pullambhatla; Kristie Stone; Gilbert Green; Zaver M Bhujwalla; Martin G Pomper
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

9.  Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases.

Authors:  Margaret Gil; Mukund Seshadri; Marcin P Komorowski; Scott I Abrams; Danuta Kozbor
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

10.  Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CT.

Authors:  Sridhar Nimmagadda; Mrudula Pullambhatla; Martin G Pomper
Journal:  J Nucl Med       Date:  2009-06-12       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.